Document is current
Any future updates will be listed below
-
Authors
Lagatie, Ole
Verheyen, Ann
Van Asten, Stijn
Odiere, Maurice R.
Djuardi, Yenny
Levecke, Bruno
Vlaminck, Johnny
Mekonnen, Zeleke
Dana, Daniel
T’Kindt, Ruben
Sandra, Koen
van Outersterp, Rianne
Oomens, Jos
Lin, Ronghui
Dillen, Lieve
Vreeken, Rob
Cuyckens, Filip
Stuyver, Lieven J.
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1192231)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (LIFT-731.017.419)
- License Information
-
More Information
Article History
Received: 6 April 2020
Accepted: 4 September 2020
First Online: 25 September 2020
Competing interests
: O.L., A.V., S.V.A., L.D., R.V., F.C. and L.J.S. are current employees of Janssen Pharmaceutica NV, and R.L. is current employee of Janssen Pharmaceuticals, Inc, both being Johnson and Johnson Companies and they may own stock or stock options in that company. The remaining co-authors have no conflicts of interest with the content of this article.
